Depending on the MMR germline variant, LS patients have an increased risk of other primary cancers, such as ovarian, small bowel, prostate, biliary tract, pancreatic, brain (glioblastoma), cutaneous, and urothelial (ureter, renal pelvis, and bladder) cancer [6]. This evidence concerns the gene MRC1 and cancer.